These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Metabolic and cardiovascular effects of androgen deprivation therapy. Hakimian P; Blute M; Kashanian J; Chan S; Silver D; Shabsigh R BJU Int; 2008 Dec; 102(11):1509-14. PubMed ID: 18727614 [TBL] [Abstract][Full Text] [Related]
24. GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mouse model. Hopmans SN; Duivenvoorden WC; Werstuck GH; Klotz L; Pinthus JH Urol Oncol; 2014 Nov; 32(8):1126-34. PubMed ID: 25242517 [TBL] [Abstract][Full Text] [Related]
25. [What is the interest of Klinefelter's syndrome for (child) psychiatrists?]. Kebers F; Janvier S; Colin A; Legros JJ; Ansseau M Encephale; 2002; 28(3 Pt 1):260-5. PubMed ID: 12091788 [TBL] [Abstract][Full Text] [Related]
26. Benperidol in the treatment of sexual offenders. Field LH Med Sci Law; 1973 Jul; 13(3):195-6. PubMed ID: 4729109 [No Abstract] [Full Text] [Related]
27. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer. Ross RW; Small EJ J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415 [TBL] [Abstract][Full Text] [Related]
28. The hormonal treatment of sexual offenders. Field LH; Williams M Med Sci Law; 1970 Jan; 10(1):27-34. PubMed ID: 5504133 [No Abstract] [Full Text] [Related]
29. Osteoporosis and androgen-depleting drugs in sex offenders. Gooren LJ; Lips P; Gijs L Lancet; 2001 Apr; 357(9263):1208-9. PubMed ID: 11332437 [No Abstract] [Full Text] [Related]
30. [Role of androgen in the elderly. Problems of androgen deprivation therapy]. Tsujimura A Clin Calcium; 2013 Aug; 23(8):1185-90. PubMed ID: 23892220 [TBL] [Abstract][Full Text] [Related]
31. Metabolic complications of androgen deprivation therapy for prostate cancer. Saylor PJ; Smith MR J Urol; 2013 Jan; 189(1 Suppl):S34-42; discussion S43-4. PubMed ID: 23234628 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment of patients with paraphilic disorders and risk of sexual offending: An international perspective. Turner D; Petermann J; Harrison K; Krueger R; Briken P World J Biol Psychiatry; 2019 Oct; 20(8):616-625. PubMed ID: 29057702 [No Abstract] [Full Text] [Related]
33. Drug treatment of paraphilic and nonparaphilic sexual disorders. Guay DR Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704 [TBL] [Abstract][Full Text] [Related]
34. Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone. McConaghy N; Blaszczynski A; Kidson W Acta Psychiatr Scand; 1988 Feb; 77(2):199-206. PubMed ID: 2896429 [TBL] [Abstract][Full Text] [Related]